Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,645 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complement inhibitors for age-related macular degeneration.
Tzoumas N, Riding G, Williams MA, Steel DH. Tzoumas N, et al. Among authors: williams ma. Cochrane Database Syst Rev. 2023 Jun 14;6(6):CD009300. doi: 10.1002/14651858.CD009300.pub3. Cochrane Database Syst Rev. 2023. PMID: 37314061 Review.
Complement inhibitors for age-related macular degeneration.
Williams MA, McKay GJ, Chakravarthy U. Williams MA, et al. Cochrane Database Syst Rev. 2014 Jan 15;2014(1):CD009300. doi: 10.1002/14651858.CD009300.pub2. Cochrane Database Syst Rev. 2014. PMID: 24431152 Free PMC article. Updated. Review.
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.
Gale RP, Pearce I, Eter N, Ghanchi F, Holz FG, Schmitz-Valckenberg S, Balaskas K, Burton BJL, Downes SM, Eleftheriadis H, George S, Gilmour D, Hamilton R, Lotery AJ, Patel N, Prakash P, Santiago C, Thomas S, Varma D, Walters G, Williams M, Wolf A, Zakri RH, Igwe F, Ayan F. Gale RP, et al. Br J Ophthalmol. 2020 Apr;104(4):493-499. doi: 10.1136/bjophthalmol-2019-314251. Epub 2019 Aug 5. Br J Ophthalmol. 2020. PMID: 31383649 Free PMC article. Clinical Trial.
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study.
Pennington B, Alshreef A, Flight L, Metry A, Poku E, Hykin P, Sivaprasad S, Prevost AT, Vasconcelos JC, Murphy C, Kelly J, Yang Y, Lotery A, Williams M, Brazier J. Pennington B, et al. Pharmacoeconomics. 2021 Aug;39(8):913-927. doi: 10.1007/s40273-021-01026-5. Epub 2021 Apr 26. Pharmacoeconomics. 2021. PMID: 33900585 Free PMC article. Clinical Trial.
Plasma Complement factor H in Alzheimer's Disease.
Williams MA, Haughton D, Stevenson M, Craig D, Passmore AP, Silvestri G. Williams MA, et al. J Alzheimers Dis. 2015;45(2):369-72. doi: 10.3233/JAD-142742. J Alzheimers Dis. 2015. PMID: 25589717
1,645 results